Guest guest Posted December 18, 2007 Report Share Posted December 18, 2007 > Hello,> > The following items have been posted to > <http://www.hcvadvocate.org/>www.hcvadvocate.org and > <http://www.hbvadvocate.org>www.hbvadvocate.org> > > > *** > <http://www.hcvadvocate.org/hepatitis/factsheets_pdf/reading_abstract_FS.pdf>A > Simple Guide to Reading an Abstract: Updated> Reading and interpreting an abstract can be very challenging because > there are many variables to consider. This factsheet provices general > tips for reading and understanding an abstract as well as some > important pointers for you to keep in mind while reading scientific materials> > > > ***<http://www.hcvadvocate.org/hepatitis/hepC/HCVDrugs.html>Hepatitis > C Treatments in Current Clinical Development: Updated December 14th> > > > *** > <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-235.html>HCV > ADVOCATE WEEKLY NEWS REVIEW:> > A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights> > Week Ending: December 15 th , 2007> > To download pdf version click > <http://www.hcvadvocate.org/news/NewsUpdates_pdf/News_Review_2007/NewsRev-235.pd\ f>here> > This Issue:> * > <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-235.html#_Ligand_Presents_\ Positive>Ligand > Presents Positive LGD-4665 Phase I Clinical Trial Results at the > American Society of Hematology Annual Meeting (ASH)> * > <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-235.html#_SciGen_Enters_Ag\ reement>SciGen > Enters Agreement With Nasvax Regarding Hepatitis B Vaccine> * > <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-235.html#_Hepatitis_C_vict\ ims>Hepatitis > C victims may reject settlement talks> * > <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-235.html#_XTL_Biopharmaceu\ ticals_Presents>XTL > Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus > Small Molecule Program at Hep Dart 2007 - an International Scientific > Conference on Viral Hepatitis> * > <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-235.html#_Greater_need_for\ >Greater > need for education regarding blood borne viruses> * > <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-235.html#_Bile_acid_may>Bi\ le > acid may improve hepatitis C therapy response> * > <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-235.html#_Two_on_hepatitis\ >Two > on hepatitis panel were paid by maker of fibrinogen> * > <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-235.html#_GENimmune_Receiv\ es_Orphan>GENimmune > Receives Orphan Medicinal Product Designation from European > Commission for its hepatitis C Monoclonal Antibody> * > <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-235.html#_Pharmasset_Annou\ nces_Clevudine>Pharmasset > Announces Clevudine and R7128 Presentations at HEP-DART> * > <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-235.html#_Cancer_Surveilla\ nce_Futile>Cancer > Surveillance Futile in Advanced Cirrhosis> * > <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-235.html#_ZymoGenetics_Pre\ sents_PEG-Interfero>ZymoGenetics > Presents PEG-Interferon Lambda Phase 1a Data> * > <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-235.html#_Study_shows_Hep>\ Study > shows Hep C virus can be passed along by sharing crack pipe> * > <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-235.html#_Common_children'\ s_vaccine>Common > children's vaccine recalled> * > <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-235.html#_Novelos_Therapeu\ tics_Concludes>Novelos > Therapeutics Concludes Nov-205 Hepatitis C Trial Based on Favorable > Safety Profile> * > <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-235.html#_Condoms_proposed\ _for>Condoms > proposed for n prisoners> * > <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-235.html#_Hepatitis_C_pati\ ents>Hepatitis > C patients reject settlement> * > <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-235.html#_Big_jump_in>Big > jump in hepatitis C sufferers> * > <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-235.html#_Ottawa_mayor_aga\ inst>Ottawa > mayor against crack pipe program despite hep C study> > > Thanks!> > Alan Franciscus> Executive Director, Hepatitis C Support Project> Editor-in-Chief, HCV Advocate> > > > For the Team at HCSP> > CD Mazoff, PhD> Managing Editor, Webmaster> HCV Advocate> www.hcvadvocate.org> HBV Advocate> www.hbvadvocate.org _________________________________________________________________ Don't get caught with egg on your face. Play Chicktionary! http://club.live.com/chicktionary.aspx?icid=chick_wlhmtextlink1_dec Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.